3Vote!
The Observer-Dispatch News RSS (Free subscription) | 11/23/2009
Burlington, N.C.-based Laboratory Corporation of America Holdings has announced plans to purchase Centrex Clinical Laboratories, according to a news release. Centrex, which employs about 365 people, is owned by Faxton-St. Luke’s Healthcare and has four labs and 21 patient service centers throughout Central New York. No layoffs or lab or service center closings are planned, and Centrex will continue...
4Vote!
bharatbook | 11/21/2009
EXACT Sciences Corporation (EXACT) is a molecular diagnostics company engaged in the development of deoxyribonucleic acid (DNA)-based technologies used in the detection of cancer. It principally focuses on the identification of colorectal cancer, the second leading cause of cancer death in the U.S. and the leading cause of cancer death among non-smokers. The company licensed some of its technologies
4Vote!
Market Wire (Free subscription) | 10/27/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Laboratory Corp. of America Holdings (NYSE: LH), Coach Inc. (NYSE: COH), Amdocs Ltd. (NYSE: DOX), Concho Resources Inc....
4Vote!
Market Wire (Free subscription) | 10/16/2009
LONDON (MARKET WIRE) Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. Today we began research on Dominion Resources Inc. (NYSE: D), Kroger Co. (NYSE: KR), Deutsche Telekom AG (NYSE: DT), Laboratory Corp. of America Holdings (NYSE: LH), Delta Air Lines Inc....
4Vote!
Market Wire (Free subscription) | 10/07/2009
NEW DELHI, INDIA (MARKET WIRE) W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued free ratings reports on the following six companies: AMR Corporation (NYSE: AMR), Lexington Realty Trust (NYSE: LXP), Mitsubishi UFJ Financial Group Inc. (NYSE: MTU), China Mobile Limited (NYSE: CHL), Laboratory...
4Vote!
Miami Herald (Free subscription) | 09/16/2009
A Credit Suisse analyst downgraded shares of medical laboratory operators Quest Diagnostics Inc. and Laboratory Corp. of America Holdings Wednesday, predicting slower growth and smaller profits in 2010.
5Vote!
Seattle Times (Free subscription) | 09/16/2009
A Credit Suisse analyst downgraded shares of medical laboratory operators Quest Diagnostics Inc. and Laboratory Corp. of America Holdings Wednesday, predicting slower growth and smaller profits in 2010.
5Vote!
San Diego Union (Free subscription) | 09/16/2009
A Credit Suisse analyst downgraded shares of medical laboratory operators Quest Diagnostics Inc. and Laboratory Corp. of America Holdings Wednesday, predicting slower growth and smaller profits in 2010.
5Vote!
Seattle Post-Intelligencer (Free subscription) | 09/16/2009
NEW YORK -- A Credit Suisse analyst downgraded shares of medical laboratory operators Quest Diagnostics Inc. and Laboratory Corp. of America Holdings Wednesday, predicting slower growth and smaller profits in 2010.
4Vote!
Market Wire (Free subscription) | 08/28/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Laboratory Corp. of America Holdings (NYSE: LH), SunTrust Banks Inc. (NYSE: STI), United Microelectronics Corporation (NYSE:...
The last article published by a user on Laboratory Corp. of America Holdings :
4Vote!
bharatbook | 11/21/2009
EXACT Sciences Corporation (EXACT) is a molecular diagnostics company engaged in the development of deoxyribonucleic acid (DNA)-based technologies used in the detection of cancer. It principally focuses on the identification of colorectal cancer, the second leading cause of cancer death in the U.S. and the leading cause of cancer death among non-smokers. The company licensed some of its technologies